CD40LG and toxoplasmosis: First, by only selecting local therapy (intravitreal injections) to treat toxoplasmosis in pregnancy, this strategy does not address the possibility of systemic infection and offers little protection to the fetus since the patient was IgM positive indicating recently acquired toxoplasmosis.